Prohance and Protein urine - a phase IV clinical study of FDA data

Summary:

We study 4,854 people who take Prohance or have Protein urine. No report of Protein urine is found in people who take Prohance.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

No report is found.

What is Prohance?

Prohance has active ingredients of gadoteridol. eHealthMe is studying from 3,618 Prohance users for its effectiveness, alternative drugs and more.

What is Protein Urine?

Protein urine is found to be associated with 910 drugs and 502 conditions by eHealthMe.

Do you take Prohance and have Protein urine?

Check whether Protein urine is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Protein urine and when was it recovered:

Protein urine in Prohance

Expand to all the drugs that have ingredients of gadoteridol:

Protein urine and drugs with ingredients of gadoteridol

Alternative drugs to, pros and cons of Prohance:

Prohance (3,618 reports)

Protein urine treatments and more:

Protein urine (1,236 reports)

COVID vaccines that are related to Protein urine:

All the drugs that are associated with Protein urine:

Protein urine

All the conditions that are associated with Protein urine:

Protein urine

How the study uses the data?

The study uses data from the FDA. It is based on gadoteridol (the active ingredients of Prohance) and Prohance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.